TD Cowen downgraded Molina Healthcare (MOH) to Hold from Buy with an unchanged price target of $203. The firm sees potential for several years of medical loss ratio pressure as states face budget deficits and lingering effects of redeterminations. The downgrade is not a reflection of Molina’s management, but of the operating environment, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- AMD upgraded, Micron downgraded: Wall Street’s top analyst calls
- Molina Healthcare price target raised to $210 from $180 at Truist
- Molina Healthcare price target raised to $204 from $163 at Morgan Stanley
- Molina Healthcare initiated with a Neutral at Goldman Sachs
- Molina Healthcare price target raised to $231 from $198 at Wells Fargo